Metformin Reverses the Effects of Angiotensin 2 in Human Mammary Arteries by Modulating the Expression of Nitric Oxide Synthases
By:
References
- 1. Becher UM, Endtmann C, Tiyerili V, Nickenig G, Werner N. Endothelial Damage and Regeneration: The Role of the Renin-Angiotensin-Aldosterone System. Current Hypertension Reports. 2011;13(1):86-92.
- 2. Silva GM, França-Falcão MS, Calzerra NTM, Luz MS, Gadelha DDA, Balarini CM, et al. Role of Renin- Angiotensin System Components in Atherosclerosis: Focus on Ang-II, ACE2, and Ang-1-7. Frontiers in physiology. 2020;11:1067.
- 3. Lüscher TF. Endothelial dysfunction: the role and impact of the renin-angiotensin system. Heart. 2000;84(suppl 1):i20.
- 4. Ruiz-Ortega M, Lorenzo O, Rupérez M, Esteban V, Suzuki Y, Mezzano S, et al. Role of the Renin- Angiotensin System in Vascular Diseases. Hypertension (Dallas, Tex : 1979). 2001;38(6):1382-7.
- 5. Rena G, Lang CC. Repurposing Metformin for Cardiovascular Disease. Circulation. 2018;137(5):422-4.
- 6. Manzella D, Grella R, Esposito K, Giugliano D, Barbagallo M, Paolisso G. Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration. Am J Hypertens. 2004;17(3):223-7.
- 7. de Jager J, Kooy A, Schalkwijk C, van der Kolk J, Lehert P, Bets D, et al. Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial. J Intern Med. 2014;275(1):59-70.
- 8. Wulffele MG, Kooy A, Lehert P, Bets D, Donker AJ, Stehouwer CD. Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin? Diabet Med. 2005;22(7):907-13.
- 9. de Aguiar LG, Bahia LR, Villela N, Laflor C, Sicuro F, Wiernsperger N, et al. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance. Diabetes care. 2006;29(5):1083-9.
- 10. Ionică LN, Gaiță L, Bînă AM, Soșdean R, Lighezan R, Sima A, et al. Metformin alleviates monoamine oxidaserelated vascular oxidative stress and endothelial dysfunction in rats with diet-induced obesity. Mol Cell Biochem. 2021;476(11):4019-29.
- 11. Liu J, Aylor KW, Chai W, Barrett EJ, Liu Z. Metformin prevents endothelial oxidative stress and microvascular insulin resistance during obesity development in male rats. American Journal of Physiology-Endocrinology and Metabolism. 2022;322(3):E293-E306.
- 12. Ding Y, Zhou Y, Ling P, Feng X, Luo S, Zheng X, et al. Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. Theranostics. 2021;11(19):9376-96.
- 13. Cameron AR, Morrison VL, Levin D, Mohan M, Forteath C, Beall C, et al. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circulation research. 2016;119(5):652-65.
- 14. Bai B, Chen H. Metformin: A Novel Weapon Against Inflammation. Front Pharmacol. 2021;12:622262.
- 15. LaMoia TE, Shulman GI. Cellular and Molecular Mechanisms of Metformin Action. Endocrine reviews. 2020.
- 16. Danila MD, Privistirescu A, Duicu OM, Ratiu CD, Angoulvant D, Muntean DM, et al. The effect of purinergic signaling via the P2Y11 receptor on vascular function in a rat model of acute inflammation. Molecular and cellular biochemistry. 2017.
- 17. Duicu OM, Lighezan R, Sturza A, Balica R, Vaduva A, Feier H, et al. Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts. Oxidative medicine and cellular longevity. 2016;2016:8470394.
- 18. Sturza A, Leisegang MS, Babelova A, Schröder K, Benkhoff S, Loot AE, et al. Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta. Hypertension. 2013;62(1):140-6.
- 19. Schubert M, Hansen S, Leefmann J, Guan K. Repurposing Antidiabetic Drugs for Cardiovascular Disease. Front Physiol. 2020;11:568632.
- 20. Ala M, Ala M. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? ACS Pharmacology & Translational Science. 2021;4(6):1747-70.
- 21. Giaccari A, Solini A, Frontoni S, Del Prato S. Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? Diabetes Care. 2021;44(3): 647-54.
- 22. Katakam PV, Ujhelyi MR, Hoenig M, Miller AW. Metformin improves vascular function in insulinresistant rats. Hypertension (Dallas, Tex:1979). 2000; 35(1 Pt 1):108-12.
- 23. Davis BJ, Xie Z, Viollet B, Zou MH. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes. 2006;55(2):496-505.
- 24. Gundewar S, Calvert JW, Jha S, Toedt-Pingel I, Ji SY, Nunez D, et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res. 2009;104(3):403-11.
- 25. Yu JW, Deng YP, Han X, Ren GF, Cai J, Jiang GJ. Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice. Cardiovascular diabetology. 2016;15:88.
- 26. Davis BJ, Xie Z, Viollet B, Zou M-H. Activation of the AMP-Activated Kinase by Antidiabetes Drug Metformin Stimulates Nitric Oxide Synthesis In Vivo by Promoting the Association of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase. Diabetes. 2006;55(2):496-505.
- 27. Sartoretto JL, Melo GA, Carvalho MH, Nigro D, Passaglia RT, Scavone C, et al. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression. Life sciences. 2005;77(21):2676-89.
- 28. Kim SA, Choi HC. Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells. Biochem Biophys Res Commun. 2012;425(4):866-72.
- 29. Dawood AF, Maarouf A, Alzamil NM, Momenah MA, Shati AA, Bayoumy NM, et al. Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury. Biomedicines. 2022;10(7).
- 30. Matsumoto T, Noguchi E, Ishida K, Kobayashi T, Yamada N, Kamata K. Metformin normalizes endothelial function by suppressing vasoconstrictor prostanoids in mesenteric arteries from OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol. 2008;295(3):H1165-h76.
- 31. Merce AP, Ionică LN, Bînă AM, Popescu S, Lighezan R, Petrescu L, et al. Monoamine oxidase is a source of cardiac oxidative stress in obese rats: the beneficial role of metformin. Molecular and cellular biochemistry. 2022.
- 32. Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, doubleblind, placebo-controlled study. J Am Coll Cardiol. 2006;48(5):956-63.
- 33. Meaney E, Vela A, Samaniego V, Meaney A, Asbún J, Zempoalteca JC, et al. Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study. Clin Exp Pharmacol Physiol. 2008;35(8):895-903.
Language: English
Page range: 201 - 207
Submitted on: Jul 19, 2022
Accepted on: Aug 4, 2022
Published on: Sep 20, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2022 Adrian Merce, Darius G. Buriman, Ana Lascu, Anca M. Bînă, Horea B. Feier, Lucian Petrescu, Claudia Borza, Adrian Sturza, Danina M. Muntean, Octavian M. Crețu, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.